Finance Director

Head Of Gross To Net

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver 40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centered on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.

Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.

Reporting to the Sr. Finance Director, Head of Gross to Net, this role serves as a strategic finance partner to US Commercial Finance teams, the US CFO and Market Access leaders. The position provides decision support to the Contract Review Board and Strategic Pricing Committee, translating pricing, contracting, policy, and market dynamics into clear financial implications and recommendations.

As a key member of US Commercial Finance, the role leads gross-to-net analysis, reporting, and forecasting to improve performance, strengthen controls, and support business unit objectives. It connects external shifts and internal priorities to actionable insight that informs planning, trade-off decisions, and execution across a complex matrix.

The role requires strong business judgment, executive-level communication, and the ability to simplify complex issues into clear decision support for senior leadership while operating effectively across a sophisticated matrixed environment.

GSK's portfolio spans three product areas: vaccines, specialty and general medicines and our focus is to deliver better and faster for patients globally. Our unrivalled vaccine portfolio targets infectious diseases at every stage of life, helping to reduce the burden of disease for hundreds of millions of people. GSK has exceptional capabilities in vaccine science and technologies, including adjuvant/protein and mRNA. In specialty medicines, we are at the forefront of HIV prevention and treatment, and we are building our presence in key therapeutic areas such as oncology and immuno-inflammation. General medicines include our inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases.

Key Responsibilities:

• Lead the gross-to-net strategy team and process for finance for the US portfolio - integrating pricing, contracting, and rebate dynamics into a clear enterprise view of net sales performance, opportunities and risk
• Guide team to drive enterprise contract and pricing analysis and recommendation through rigorous assessment of business cases, disciplined governance, and cross-functional alignment
• Understand US policy, market access, payer, provider, and competitive shifts with our internal matrix stakeholders; translate external signals into financial implications, scenarios, and clear recommendations
• Frame complex GTN and portfolio issues and opportunities into clear trade-offs, risks, and options that accelerate senior leadership decision making
• Leverage automation and appropriate AI/agentic agents, simplify processes and standardize output to optimize decision frameworks at scale that improve speed, stakeholder clarity and enterprise impact.
• Anticipate future information needs and evolve finance capabilities, analytics, and decision support to meet a changing US market environment
• Partner proactively across the matrix to shape business plans and long-range forecasts, clarify decision rights, and align stakeholders on outcomes
• Lead and coach a high-performing team by coaching, upskilling, and raising capability to deliver greater business impact and stronger judgment across priorities
• Maintain strong financial governance and compliance while adapting quickly to evolving business needs and information requirements

Basic Qualifications:

• BS/BA and 8+ years of relevant pharmaceutical finance, market access, pricing, contracting, or analytics experience
• Proven finance leadership with ownership, sound judgment, and the ability to influence across a matrix
• Experience with gross-to-net and US market access, including policy, legislative, payer, provider, and competitive dynamics
• Strategic and analytical capability, including financial modeling, scenario analysis, and decision-oriented problem solving
• Ability to translate analysis into clear, executive-ready recommendations that drive action
• Understanding of accounting standards, financial controls, and governance
• Demonstrated ability to simplify processes, standardize outputs, and improve decision support at scale
• Experience developing others through feedback, stretch work, and knowledge sharing
• Collaboration and communication skills, with the ability to build trust and align stakeholders on outcomes
• Proven ability to prioritize effectively, adapt to change, and deliver high-quality work under tight deadlines

Preferred Qualifications:

• MBA, CPA, or equivalent advanced finance or business qualification
• Deep experience navigating payer, provider, legislative, and market access dynamics to inform strategy and business decisions and understanding of specialty trade channels, pricing, reimbursement, and market access strategy
• Ability to strengthen team analytics, decision frameworks, and stakeholder partnership in pricing and contracting environments
• Deep knowledge of US market access business models and customer dynamics, including PBMs, health plans, providers, pharmacies, hospitals, clinics, and government pricing
• Experience applying advanced analytics and scenario thinking to support complex commercial and financial decisions
• Track record of raising team capability through coaching, knowledge sharing, and continuous improvement